Literature DB >> 24156914

Pathogenesis and clinical implications of optic disk hemorrhage in glaucoma.

Min Hee Suh1, Ki Ho Park2.   

Abstract

The association between optic disk hemorrhage and glaucoma has been studied for many years. Recently, randomized clinical trials have confirmed that disk hemorrhage is a risk factor for development and progression of glaucoma. Disk hemorrhage is more commonly detected in open-angle glaucoma with normal tension than in open-angle glaucoma with high tension. Development of disk hemorrhage possibly is associated with the biomechanical properties of the lamina cribrosa and surrounding tissues, including the intraocular pressure (IOP)-cerebrospinal pressure gradient, arterial pressure, and venous pressure. Disk hemorrhage may be a marker of rapid glaucoma progression, in that localized subclinical structural change predisposes to disk hemorrhage, after which subsequent disease progression is accelerated, and recurrent optic disk hemorrhages are related to rapid structural progression of glaucomatous damage. IOP-lowering therapy can be helpful in halting post-hemorrhage glaucoma progression.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  glaucoma; optic disk hemorrhage; pathogenesis; risk factor

Mesh:

Year:  2013        PMID: 24156914     DOI: 10.1016/j.survophthal.2013.03.005

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  9 in total

1.  Thirteen-Year Follow-up of Optic Disc Hemorrhages in the Ocular Hypertension Treatment Study.

Authors:  Donald L Budenz; Julia Beiser Huecker; Steven J Gedde; Mae Gordon; Michael Kass
Journal:  Am J Ophthalmol       Date:  2016-11-07       Impact factor: 5.258

2.  Clinical characteristics of glaucoma patients with disc hemorrhage in different locations.

Authors:  Yun Hsia; Chien-Chia Su; Tsing-Hong Wang; Jehn-Yu Huang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-06-13       Impact factor: 3.117

3.  The impact of disc hemorrhage studies on our understanding of glaucoma: a systematic review 50 years after the rediscovery of disc hemorrhage.

Authors:  Tetsuya Yamamoto
Journal:  Jpn J Ophthalmol       Date:  2018-11-21       Impact factor: 2.447

4.  Optical Coherence Tomography Angiography Vessel Density in Glaucomatous Eyes with Focal Lamina Cribrosa Defects.

Authors:  Min Hee Suh; Linda M Zangwill; Patricia Isabel C Manalastas; Akram Belghith; Adeleh Yarmohammadi; Felipe A Medeiros; Alberto Diniz-Filho; Luke J Saunders; Siamak Yousefi; Robert N Weinreb
Journal:  Ophthalmology       Date:  2016-08-31       Impact factor: 12.079

5.  Deep Retinal Layer Microvasculature Dropout Detected by the Optical Coherence Tomography Angiography in Glaucoma.

Authors:  Min Hee Suh; Linda M Zangwill; Patricia Isabel C Manalastas; Akram Belghith; Adeleh Yarmohammadi; Felipe A Medeiros; Alberto Diniz-Filho; Luke J Saunders; Robert N Weinreb
Journal:  Ophthalmology       Date:  2016-10-18       Impact factor: 12.079

6.  Development of visual field defect after first-detected optic disc hemorrhage in preperimetric open-angle glaucoma.

Authors:  Hae Jin Kim; Yong Ju Song; Young Kook Kim; Jin Wook Jeoung; Ki Ho Park
Journal:  Jpn J Ophthalmol       Date:  2017-03-29       Impact factor: 2.447

Review 7.  [Current aspects on the management of normal tension glaucoma].

Authors:  M Töteberg-Harms; A Rosentreter; A Lappas; J Funk; T S Dietlein
Journal:  Ophthalmologe       Date:  2015-11       Impact factor: 1.059

8.  Longitudinal Analysis of Serum Autoantibody-Reactivities in Patients with Primary Open Angle Glaucoma and Optic Disc Hemorrhage.

Authors:  Katrin Lorenz; Sabine Beck; Munir M Keilani; Joanna Wasielica-Poslednik; Norbert Pfeiffer; Franz H Grus
Journal:  PLoS One       Date:  2016-12-28       Impact factor: 3.240

9.  Optic disk hemorrhage and vitreous hemorrhage after phacoemulsification in a normal tension glaucoma patient: A case report.

Authors:  Rongrong Hu; Liping Shen; Xiaoyu Wang
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.